{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:25:33Z","timestamp":1793881533375,"version":"4.7.0"},"reference-count":36,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2024,4,4]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>We aimed to investigate the clinical, imaging and fluid biomarker characteristics in patients with antidiacylglycerol lipase alpha (DAGLA)-autoantibody-associated cerebellitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum and cerebrospinal fliud (CSF) samples from four index patients were subjected to comprehensive autoantibody screening by indirect immunofluorescence assay (IIFA). Immunoprecipitation, mass spectrometry and recombinant protein assays were used to identify the autoantigen. Sera from 101 patients with various neurological symptoms and a similar tissue staining pattern as the index patient samples, and 102 healthy donors were analysed in recombinant cell-based IIFA (RC-IIFA) with the identified protein. Epitope characterisation of all positive samples was performed via ELISA, immunoblot, immunoprecipitation and RC-IIFA using different DAGLA fragments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All index patients were relatively young (age: 18\u201334) and suffered from pronounced gait ataxia, dysarthria and visual impairments. Paraclinical hallmarks in early-stage disease were inflammatory CSF changes and cerebellar cortex hyperintensity in MRI. Severe cerebellar atrophy developed in three of four patients within 6 months. All patient samples showed the same unclassified IgG reactivity with the cerebellar molecular layer. DAGLA was identified as the target antigen and confirmed by competitive inhibition experiments and DAGLA-specific RC-IIFA. In RC-IIFA, serum reactivity against DAGLA was also found in 17\/101 disease controls, including patients with different clinical phenotypes than the one of the index patients, and in 1\/102 healthy donors. Epitope characterisation revealed that 17\/18 anti-DAGLA-positive control sera reacted with a C-terminal intracellular DAGLA 583\u20131042 fragment, while the CSF samples of the index patients targeted a conformational epitope between amino acid 1 and 157.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We propose that anti-DAGLA autoantibodies detected in CSF, with a characteristic tissue IIFA pattern, represent novel biomarkers for rapidly progressive cerebellitis.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2024-333458","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T17:32:47Z","timestamp":1714066367000},"page":"1064-1076","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of DAGLA as an autoantibody target in cerebellar ataxia"],"prefix":"10.1136","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-4676","authenticated-orcid":false,"given":"Ramona","family":"Miske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Scharf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Borowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Corty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika-Johanna","family":"Loritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Rombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Laureys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Rochow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Radzimski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Schnitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominica","family":"Ratuszny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8550-335X","authenticated-orcid":false,"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-2897","authenticated-orcid":false,"given":"Mike P","family":"Wattjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Denno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Guerti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Oyaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Benkhadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna Ines","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"Wandinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Teegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt-Wolfram","family":"S\u00fchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"2024101603401080000_95.11.1064.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx189"},{"key":"2024101603401080000_95.11.1064.2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.683048","article-title":"Update in autoimmune movement disorders: newly described antigen targets in autoimmune and Paraneoplastic cerebellar ataxia","volume":"12","author":"Garza","year":"2021","journal-title":"Front Neurol"},{"key":"2024101603401080000_95.11.1064.3","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for Paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024101603401080000_95.11.1064.4","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000987","article-title":"Autoantibodies against the Purkinje cell protein Rgs8 in Paraneoplastic cerebellar syndrome","volume":"8","author":"Miske","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024101603401080000_95.11.1064.5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/00207454.2017.1412967","article-title":"Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells","volume":"128","author":"Schwenkenbecher","year":"2018","journal-title":"Int J Neurosci"},{"key":"2024101603401080000_95.11.1064.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0657-5","article-title":"Intrathecal synthesis of anti-Hu antibodies distinguishes patients with Paraneoplastic peripheral neuropathy and encephalitis","volume":"16","author":"Schwenkenbecher","year":"2016","journal-title":"BMC Neurol"},{"key":"2024101603401080000_95.11.1064.7","first-page":"67","article-title":"Paraneoplastic neurologic disorders","volume":"23","author":"Gilligan","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2024101603401080000_95.11.1064.8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010854"},{"key":"2024101603401080000_95.11.1064.9","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1212\/WNL.0000000000008061","article-title":"Autoimmune gait disturbance accompanying Adaptor Protein-3B2-IgG","volume":"93","author":"Honorat","year":"2019","journal-title":"Neurology"},{"key":"2024101603401080000_95.11.1064.10","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000307","article-title":"Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration","volume":"4","author":"Miske","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024101603401080000_95.11.1064.11","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000612","article-title":"Neurochondrin neurological autoimmunity","volume":"6","author":"Shelly","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024101603401080000_95.11.1064.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2006.08.011"},{"key":"2024101603401080000_95.11.1064.13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000255","article-title":"Autoantibodies against glutamate receptor Delta2 after allogenic stem cell transplantation","volume":"3","author":"Miske","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024101603401080000_95.11.1064.14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000474","article-title":"Autoimmune septin-5 cerebellar ataxia","volume":"5","author":"Honorat","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024101603401080000_95.11.1064.15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/B978-0-444-64189-2.00021-4","article-title":"Immune-mediated Ataxias","volume":"155","author":"Joubert","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024101603401080000_95.11.1064.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00543-w"},{"key":"2024101603401080000_95.11.1064.17","doi-asserted-by":"crossref","first-page":"103287","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2024101603401080000_95.11.1064.18","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-021-01363-3"},{"key":"2024101603401080000_95.11.1064.19","doi-asserted-by":"crossref","DOI":"10.1186\/2045-8118-9-14","article-title":"Usefulness of antibody index assessment in cerebrospinal fluid from patients negative for total-IgG Oligoclonal bands","volume":"9","author":"Jarius","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"2024101603401080000_95.11.1064.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-023-02718-9","article-title":"Septin-3 Autoimmunity in patients with Paraneoplastic cerebellar ataxia","volume":"20","author":"Miske","year":"2023","journal-title":"J Neuroinflammation"},{"key":"2024101603401080000_95.11.1064.21","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0054-06.2006"},{"key":"2024101603401080000_95.11.1064.22","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200305129"},{"key":"2024101603401080000_95.11.1064.23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5693-09.2010"},{"key":"2024101603401080000_95.11.1064.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.01.021"},{"key":"2024101603401080000_95.11.1064.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.03.033"},{"key":"2024101603401080000_95.11.1064.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.11.001"},{"key":"2024101603401080000_95.11.1064.27","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00086","article-title":"Diacylglycerol Lipase alpha knockout mice demonstrate metabolic and behavioral phenotypes similar to those of Cannabinoid receptor 1 knockout mice","volume":"6","author":"Powell","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024101603401080000_95.11.1064.28","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn283"},{"key":"2024101603401080000_95.11.1064.29","unstructured":"Storey E , Gardner RJM . Spinocerebellar ataxia type 20. In: Adam MP , Feldman J , Mirzaa GM , et al ., eds. GeneReviews((R)). Seattle (WA), 1993."},{"key":"2024101603401080000_95.11.1064.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70310-1"},{"key":"2024101603401080000_95.11.1064.31","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23550"},{"key":"2024101603401080000_95.11.1064.32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12311-021-01346-4","article-title":"Anti-TR\/DNER antibody-associated cerebellar ataxia: a systematic review","volume":"21","author":"Campana","year":"2022","journal-title":"Cerebellum"},{"key":"2024101603401080000_95.11.1064.33","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200018","article-title":"Cerebellar ataxia with anti-DNER antibodies: outcomes and immunologic features","volume":"9","author":"Peter","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024101603401080000_95.11.1064.34","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10485.1","article-title":"Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease","volume":"6","author":"Kano","year":"2017","journal-title":"F1000Res"},{"key":"2024101603401080000_95.11.1064.35","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20614"},{"key":"2024101603401080000_95.11.1064.36","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21050"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2024-333458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T10:41:16Z","timestamp":1729075276000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2024-333458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,10,16]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/jnnp-2024-333458"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2024-333458","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]}}}